NOTCH1 and non-small cell lung carcinoma: Some studies showed a tumor-promoting effect for Notch1 signaling and thus linked it to a poor prognosis in breast cancer (14), gastric cancer (15, 16), as well as NSCLC, and therefore proposed the possible use of Notch inhibitors in cancer treatment (17–19).